A Di Florio1, K Putnam1, M Altemus2, G Apter3, V Bergink4, J Bilszta5, R Brock6, A Buist5, K M Deligiannidis7, E Devouche8, C N Epperson9, C Guille10, D Kim9, P Lichtenstein11, P K E Magnusson11, P Martinez12, T Munk-Olsen13, J Newport14, J Payne15, B W Penninx16, M O'Hara6, E Robertson-Blackmore17, S J Roza4, K M Sharkey18, S Stuart6, H Tiemeier4, A Viktorin11, P J Schmidt12, P F Sullivan1, Z N Stowe19, K L Wisner20, I Jones21, D R Rubinow1, S Meltzer-Brody1. 1. Department of Psychiatry,The University of North Carolina at Chapel Hill,Chapel Hill, NC,USA. 2. Department of Psychiatry,Weill Cornell Medical College,New York, NY,USA. 3. Erasme Hospital, Paris Diderot University,Paris,France. 4. Department of Psychiatry/Psychology,Erasmus MC,Rotterdam,The Netherlands. 5. Women's Mental Health, University of Melbourne,Melbourne,VIC,Australia. 6. Department of Psychological and Brain Sciences,The University of Iowa,Iowa City,IA,USA. 7. Departments of Psychiatry and Obstetrics and Gynecology, Hofstra Northwell School of Medicine, Glen Oaks, NY,USA. 8. Erasme Hospital, Paris Descartes University,Paris,France. 9. Department of Psychiatry,University of Pennsylvania,Philadelphia,PA,USA. 10. Department of Psychiatry,Medical University of South Carolina,Charleston,SC,USA. 11. Department of Medical Epidemiology and Biostatistics,Karolinska Institute,Stockholm,Sweden. 12. Behavioral Endocrinology Branch,National Institute of Mental Health, National Institutes of Health, Health and Human Services,Bethesda,MD,USA. 13. Department of Economics and Business,National Centre for Integrated Register-based Research, Aarhus University,Aarhus,Denmark. 14. Department of Psychiatry,University of Miami,Miami,FL,USA. 15. Department of Psychiatry,The Johns Hopkins University,Baltimore,MD,USA. 16. Department of Psychiatry,VU University Medical Center,Amsterdam,The Netherlands. 17. Department of Family Medicine,Halifax Health,Daytona Beach,FL,USA. 18. Department of Psychiatry,Alpert Medical School of Brown University/Rhode Island Hospital,Providence,RI,USA. 19. Department of Psychiatry,University of Arkansas for Medical Sciences,Little Rock,AR,USA. 20. Asher Center for the Study and Treatment of Depressive Disorders, Northwestern University Feinberg School of Medicine,Chicago,IL,USA. 21. Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University School of Medicine,Cardiff,UK.
Abstract
BACKGROUND: Universal screening for postpartum depression is recommended in many countries. Knowledge of whether the disclosure of depressive symptoms in the postpartum period differs across cultures could improve detection and provide new insights into the pathogenesis. Moreover, it is a necessary step to evaluate the universal use of screening instruments in research and clinical practice. In the current study we sought to assess whether the Edinburgh Postnatal Depression Scale (EPDS), the most widely used screening tool for postpartum depression, measures the same underlying construct across cultural groups in a large international dataset. METHOD: Ordinal regression and measurement invariance were used to explore the association between culture, operationalized as education, ethnicity/race and continent, and endorsement of depressive symptoms using the EPDS on 8209 new mothers from Europe and the USA. RESULTS: Education, but not ethnicity/race, influenced the reporting of postpartum depression [difference between robust comparative fit indexes (∆*CFI) 0.01), but not between European countries (∆*CFI < 0.01). CONCLUSIONS: Investigators and clinicians should be aware of the potential differences in expression of phenotype of postpartum depression that women of different educational backgrounds may manifest. The increasing cultural heterogeneity of societies together with the tendency towards globalization requires a culturally sensitive approach to patients, research and policies, that takes into account, beyond rhetoric, the context of a person's experiences and the context in which the research is conducted.
BACKGROUND: Universal screening for postpartum depression is recommended in many countries. Knowledge of whether the disclosure of depressive symptoms in the postpartum period differs across cultures could improve detection and provide new insights into the pathogenesis. Moreover, it is a necessary step to evaluate the universal use of screening instruments in research and clinical practice. In the current study we sought to assess whether the Edinburgh Postnatal Depression Scale (EPDS), the most widely used screening tool for postpartum depression, measures the same underlying construct across cultural groups in a large international dataset. METHOD: Ordinal regression and measurement invariance were used to explore the association between culture, operationalized as education, ethnicity/race and continent, and endorsement of depressive symptoms using the EPDS on 8209 new mothers from Europe and the USA. RESULTS: Education, but not ethnicity/race, influenced the reporting of postpartum depression [difference between robust comparative fit indexes (∆*CFI) 0.01), but not between European countries (∆*CFI < 0.01). CONCLUSIONS: Investigators and clinicians should be aware of the potential differences in expression of phenotype of postpartum depression that women of different educational backgrounds may manifest. The increasing cultural heterogeneity of societies together with the tendency towards globalization requires a culturally sensitive approach to patients, research and policies, that takes into account, beyond rhetoric, the context of a person's experiences and the context in which the research is conducted.
Authors: Roch Cantwell; Thomas Clutton-Brock; Griselda Cooper; Andrew Dawson; James Drife; Debbie Garrod; Ann Harper; Diana Hulbert; Sebastian Lucas; John McClure; Harry Millward-Sadler; James Neilson; Catherine Nelson-Piercy; Jane Norman; Colm O'Herlihy; Margaret Oates; Judy Shakespeare; Michael de Swiet; Catherine Williamson; Valerie Beale; Marian Knight; Christopher Lennox; Alison Miller; Dharmishta Parmar; Jane Rogers; Anna Springett Journal: BJOG Date: 2011-03 Impact factor: 6.531
Authors: K S Kendler; S H Aggen; Y Li; C M Lewis; G Breen; D I Boomsma; M Bot; B W J H Penninx; J Flint Journal: Psychol Med Date: 2015-03-17 Impact factor: 7.723
Authors: J Guintivano; P F Sullivan; A M Stuebe; T Penders; J Thorp; D R Rubinow; S Meltzer-Brody Journal: Psychol Med Date: 2017-09-27 Impact factor: 7.723
Authors: Karen T Putnam; Marsha Wilcox; Emma Robertson-Blackmore; Katherine Sharkey; Veerle Bergink; Trine Munk-Olsen; Kristina M Deligiannidis; Jennifer Payne; Margaret Altemus; Jeffrey Newport; Gisele Apter; Emmanuel Devouche; Alexander Viktorin; Patrik Magnusson; Brenda Penninx; Anne Buist; Justin Bilszta; Michael O'Hara; Scott Stuart; Rebecca Brock; Sabine Roza; Henning Tiemeier; Constance Guille; C Neill Epperson; Deborah Kim; Peter Schmidt; Pedro Martinez; Arianna Di Florio; Katherine L Wisner; Zachary Stowe; Ian Jones; Patrick F Sullivan; David Rubinow; Kevin Wildenhaus; Samantha Meltzer-Brody Journal: Lancet Psychiatry Date: 2017-05-03 Impact factor: 27.083
Authors: Amy L Cochran; Blaire C Pingeton; Sherryl H Goodman; Heidemarie Laurent; Paul J Rathouz; D Jeffrey Newport; Zachary N Stowe Journal: J Abnorm Psychol Date: 2020-08-27